Skip to content

Black Spade Acquisition BIII Sale Of Stock Consideration Received On Transaction

Sale Of Stock Consideration Received On Transaction at other companies

Flanigan's Enterprises logo
Flanigan's EnterprisesBDL
$1M
Camping World Holdings logo
Camping World HoldingsCWH
$0-100%
XTI Aerospace, Inc. logo
XTI Aerospace, Inc.XTIA
$5.5M
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
$57.88M
Envoy Medical logo
Envoy MedicalCOCH
$1.68M+296%
Dogwood Therapeutics logo
Dogwood TherapeuticsDWTX
$11.4M+161%

Other financials

Income statement

See full
Operating income-$329.9K
Net income$1.1M
EPS (diluted)$0.05

Balance sheet

See full
Cash & equivalents$725.5K
Total equity-$6.2M
Total assets$174.8M

Cash flow

See full
Operating cash flow-$379.8K

Valuation

See full
Market cap$228.85M+0.2%

Returns & leverage

See full
Current ratio3.6×

Where this comes from

Reported directly by Black Spade Acquisition in its filing.

Tagged under the XBRL concept us-gaap:SaleOfStockConsiderationReceivedOnTransaction.

The official record: Black Spade Acquisition ’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Black Spade Acquisition 's sale of stock consideration received on transaction.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Black Spade Acquisition 's sale of stock consideration received on transaction?
Black Spade Acquisition (BIII) reported sale of stock consideration received on transaction of $170.21M in Q1 2026.